WebApr 6, 2024 · A high-level overview of Syros Pharmaceuticals, Inc. (SYRS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WebSep 16, 2024 · CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced the closing of its merger with Tyme Technologies, Inc., pursuant to which Syros acquired TYME, including its pipeline assets and net cash at closing of …
Syros Announces Closing of Merger with Tyme Technologies and …
WebFeb 4, 2024 · Syros Pharmaceuticals, Inc. annonce ses résultats pour le quatrième trimestre clos le 3.. 03/02: Syros Pharmaceuticals, Inc. annonce ses résultats pour l'année complète se terminant le.. 01/26: Syros Pharmaceuticals obtient le label Fast Track de la FDA pour le tamibarotène dans l.. 01/26 WebOct 3, 2024 · Syros Pharmaceuticals News: Why SYRS Stock Is Shooting 16% Higher Today. By William White, InvestorPlace Writer Dec 18, 2024. Syros Pharmaceuticals (SYRS) news for Wednesday about plans for ... eclipse クラスファイル 場所
SYRS - Stock quote for SYROS PHARMACEUTICALS, INC. - MSN
WebApr 4, 2024 · Syros Pharmaceuticals. stock was originally listed at a price of $181.50 in Jun 30, 2016. If you had invested in Syros Pharmaceuticals stock at $181.50 , your return over … WebJul 5, 2024 · CAMBRIDGE, Mass. & BEDMINSTER, N.J.-- (BUSINESS WIRE)-- Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, and TYME Technologies, Inc. (NASDAQ:TYME), today announced that the companies have entered into a definitive merger agreement pursuant to which Syros … WebSep 15, 2024 · Following the closing of the Merger, the combined company will trade on The Nasdaq Global Select Market under the ticker symbol “SYRS,” and will be led by Syros’ existing management team,... eclipse コードテンプレート